Trials / Unknown
UnknownNCT04787497
The Effect of Extra Virgin Olive Oil in People With Multiple Sclerosis
The Neuropsychological Effects of Extra-Virgin Olive Oil in People With Multiple Sclerosis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- University of Cyprus · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is an open label feasibility trial to examine the effect of a complementary treatment with High Phenolic Extra Virgin Olive Oil (HPEVOO) on the cognitive and mental health of people with Multiple Sclerosis (MS), while receiving their standard medical treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | High Phenolic Extra Virgin Olive Oil | Participants will be assigned in two groups: the Experimental Group (N= 20) will be receiving 50ml of freshly, cold-pressed, oleocanthal-rich Extra Virgin Olive Oil (EVOO) alongside their prescribed medical treatment, whereas the Control Group (N = 20) will be receiving their medical treatment as usual. The Experimental Group will be receiving the complementary treatment on a daily basis for 12 months and all participants will undergo a neuropsychological assessment at baseline, 6 months and 12 months +/- 7 days after their first assessment or beginning of treatment. |
Timeline
- Start date
- 2022-05-01
- Primary completion
- 2024-05-01
- Completion
- 2024-09-01
- First posted
- 2021-03-08
- Last updated
- 2023-11-02
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT04787497. Inclusion in this directory is not an endorsement.